combi-ad: implications for melanoma patients
Published 6 years ago • 364 plays • Length 1:27Download video MP4
Download video MP3
Similar videos
-
4:08
updates from combi-ad: dabrafenib and trametinib for melanoma
-
8:48
combi-ad: dual-targeted therapy for stage 3 melanoma
-
4:12
adjuvant therapy in melanoma: combi-ad trial
-
4:14
adjuvant therapy for melanoma: novel treatment options
-
3:02
a new standard for stage 3 braf melanoma
-
4:45
combi-ad trial: adjuvant dabrafenib plus trametinib in patients with resected stage iii braf v60...
-
1:49
combi-ad: dabrafenib plus trametinib in advanced melanoma
-
2:51
combi-ad: long-term follow-up of dabrafenib and trametinib in braf-mutated melanoma
-
5:37
selecting therapy & managing patients with braf melanoma
-
1:17
dr. dummer on combi-ad trial results in braf-mutant melanoma
-
0:48
dr. michael rotkowitz on the dabrafenib plus trametinib combination for melanoma
-
17:55
adjuvant therapy for melanoma - amaria
-
6:09
updates to adjuvant treatment for melanoma from combi-ad
-
25:50
melanoma | 2022 oneoncology conference
-
1:06:02
sysf webinar: treatment options for melanoma patients in the adjuvant setting
-
3:20
considerations surrounding adjuvant therapy in melanoma
-
8:52
adjuvant therapy for patients with melanoma
-
1:46
dr. weber on dabrafenib/trametinib approval for melanoma
-
5:54
adjuvant therapy in melanoma: safety and efficacy